Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use

International Journal of Antimicrobial Agents

Volumn 30, Issue 1, 2007, Pages 78-82

  Sule, Olajumoke ^a   Brown, Nicholas M ^a   Willocks, Lorna J ^b   Day, Jane ^a   Shankar, Sonal ^a   Palmer, Christopher R ^c   Burrows, Nigel P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Eczema; Fusidic acid; Resistance; Staphylococcus aureus; Topical

Indexed keywords

BETAMETHASONE; BETAMETHASONE PLUS FUSIDIC ACID; CIPROFLOXACIN; ERYTHROMYCIN; FUCIBET; FUCIDIN H; FUSIDATE SODIUM; FUSIDIC ACID; GENTAMICIN; METICILLIN; NEOMYCIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DRUG RESISTANCE, BACTERIAL; FEMALE; FUSIDIC ACID; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34249913951     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.02.015     Document Type: Article

References (15)

1. Leung D.Y.M., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
2. Brown E.M., and Thomas P. Fusidic acid resistance in Staphylococcus aureus isolates. Lancet 359 (2002) 803
3. Brown E.M., Wise R., Sule O., et al. Fusidic acid cream for impetigo. BMJ 324 (2002) 1394
4. Livermore D., James D., Duckworth G., et al. Fusidic-acid use and resistance. Lancet 360 (2002) 806
5. O'Neill A.J., Larsen A.R., Henriksen A.S., et al. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob Agents Chemother 48 (2004) 3594-3597
6. Shah M., and Mohanraj M. High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients. Br J Dermatol 148 (2003) 1018-1020
7. El-Zimaity D., Kearns A.M., Dawson S.J., et al. Survey, characterisation and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area. J Antimicrob Chemother 54 (2004) 441-446
8. Ravenscroft J.C., Layton A., and Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 25 (2000) 327-330
9. Mason B.W., and Howard A.J. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study. Int J Antimicrob Agents 23 (2004) 300-303
10. Andrews J.M. BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method. J Antimicrob Chemother 48 Suppl. 1 (2001) 43-57
11. Everitt B.S. Log-linear Models for Contingency Tables. In: The Analysis of Contingency Tables. second ed. (1992), Chapman and Hall, London, UK p. 93
12. Arkwright P.D., Daniel T.O., Sanyal D., et al. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol 138 (2002) 939-941
13. Mason B.W., Howard A.J., and Magee J.T. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing. J Antimicrob Chemother 51 (2003) 1033-1036
14. Menday A.P., and Noble W.C. Topical betamethasone/fusidic acid in eczema: efficacy against and emergence of resistance in Staphylococcus aureus. J Dermatol Treat 11 (2000) 143-149
15. Ravenscroft J.C., Layton A.M., Eady E.A., et al. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 148 (2003) 1010-1017